Remove Electric Remove Grant Remove Legal Remove New York City
article thumbnail

Tesla Model Y taxi fleet from Revel set for NYC launch after regulatory mix up

Teslarati

Revel, a New York City-based ridesharing company, will launch its fleet of Tesla Model Y taxis in the Big Apple in early August after a mix-up with NYC’s regulatory agency, the Taxi and Limousine Commission (TLC). The addition of Revel’s 49 Model Ys broadens New York City’s small fleet of electrified taxis.

Taxi 145
article thumbnail

Worldwide Campaign for Neurorights Notches Its First Win

Cars That Think

constitutional amendment that was passed by the National Congress of Chile and signed by the president, the people of Chile are the first in the world to be granted a new kind of human rights—“neurorights”—which advocates say are made necessary by rapid advances in neurotechnology. Thanks to a. Neurotech includes. Neurotech includes.

Chile 145
article thumbnail

How the Graphical User Interface Was Invented

Cars That Think

The Mac’s success during the 1980s spurred Apple Computer to pursue legal action over ownership of many features of the graphical user interface. Suits now being litigated could assign those innovations not to the designers and their companies, but to those who first filed for legal protection on them. In March 1989, U.S.

Design 141
article thumbnail

How Ted Hoff Invented the First Microprocessor

Cars That Think

1962, Stanford University, California, all in electrical engineering First job Planting cabbages First electronics job Technician, General Railway Signal Co., Later, with Mazor and Faggin he filed for and was granted a patent for a “memory system for a multi-chip digital computer.”) and New York City.

IDEA 115
article thumbnail

When New York City Was a Wiretapper’s Dream

Cars That Think

Subscribers whose phones were tapped at the time of the raid included a range of New York commercial interests, with assets both large and small: a modeling agency and an insurance company; an art gallery and a lead mining company; and perhaps most sensationally, two publicly traded pharmaceutical corporations with competing patent interests.